“The Undersecretary of Health Announces Changes in Drug Distribution and Efforts to Reduce Waiting Lists”
In a recent interview, Undersecretary of Health Marcello Gemmato discussed upcoming changes in drug distribution and efforts to reduce waiting lists in the healthcare system. Gemmato revealed that the Italian Medicines Agency (AIFA) will be moving certain categories of drugs from direct distribution to affiliated distribution, allowing for better access to medications in public and private pharmacies. This move is expected to improve the patient experience and increase savings for the national health system.
Gemmato emphasized the importance of treating citizens effectively to prevent illness and hospitalizations, ultimately saving money for the government. The AIFA Board of Directors is set to convene in the coming days to approve this measure, marking a significant shift in pharmaceutical governance. While there may be a short latency period as stocks are moved from hospital pharmacies to affiliated pharmacies, Gemmato is confident that collaboration with the regions will ensure a smooth transition.
On the topic of waiting lists, Gemmato acknowledged the challenges faced by the healthcare system, particularly due to services postponed during the Covid-19 pandemic. The government has allocated half a billion euros to reduce waiting times and is implementing measures to address inefficiencies, such as missed appointments and unnecessary reservations. The goal is to bring waiting times back to a normal level and improve the overall performance of the healthcare system.
Overall, Gemmato’s vision for the future of healthcare in Italy includes better access to medications, reduced waiting times, and improved efficiency in the delivery of services. With careful planning and collaboration between stakeholders, the government aims to create a healthcare system that prioritizes patient care and cost-effectiveness.